Related Experiment Video

Updated: May 29, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama

Astrid E Lammers1, Ian Adatia, Maria Jesus Del Cerro

  • 1Great Ormond Street Hospital for Children, London, UK.

Pulmonary Circulation
|August 30, 2011
PubMed

Insights

A new functional classification for pediatric pulmonary hypertension was developed, adapting adult criteria for children. This system tracks disease progression and treatment response in pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Pulmonary Medicine
  • Pediatric Critical Care

Background:

  • Pulmonary hypertension (PH) in children requires a tailored functional classification system.
  • Existing adult classifications need modification to account for pediatric-specific factors like growth and maturation.
  • The Pulmonary Vascular Research Institute (PVRI) Pediatric Task Force recognized this clinical need.

Purpose of the Study:

  • To establish a functional classification system for pediatric pulmonary hypertension.
  • To adapt the Dana Point classification criteria for use in children.
  • To provide an objective and consistent method for monitoring disease progression and treatment response in pediatric PH.

Main Methods:

  • The classification system was developed by the PVRI Pediatric Task Force.
  • It adapts the adult Dana Point classification pattern and criteria.
  • Modifications incorporate age-specific indicators, including thriving, need for supplemental feeds, and school/nursery attendance.

Main Results:

  • A consensus paper on the functional classification system was presented.
  • The system aims for consistent and objective assessment of clinical status in children.
  • It facilitates monitoring of clinical course and treatment response over time.

Conclusions:

  • The proposed classification provides a framework for managing pediatric pulmonary hypertension.
  • It aids in developing age-appropriate treatment algorithms for children with PH.
  • This system allows for consistent tracking of patient progress as they grow and mature.

More Related Videos

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: